These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 19403031

  • 1. [Induction of SMYD3 by hepatitis B virus X gene in HepG2 cells].
    Yang L, Ren J, He J, Chen LB.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):297-300. PubMed ID: 19403031
    [Abstract] [Full Text] [Related]

  • 2. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
    Xu JY, Chen LB, Xu JY, Yang Z, Wei HY, Xu RH.
    Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
    [Abstract] [Full Text] [Related]

  • 3. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference].
    Xu JY, Chen LB, Xu JY, Yang Z, Xu RH, Wei HY.
    Zhonghua Wai Ke Za Zhi; 2006 Apr 01; 44(7):481-4. PubMed ID: 16772086
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [HBx gene down-regulates miR-192 expression and inhibits apoptosis of human hepatoma cell line HepG2].
    Xie QH, He XX, Chang Y, Jiang X, Lin JS.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov 01; 19(11):857-60. PubMed ID: 22433310
    [Abstract] [Full Text] [Related]

  • 6. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D.
    Mol Carcinog; 2009 Jan 01; 48(1):56-65. PubMed ID: 18506760
    [Abstract] [Full Text] [Related]

  • 7. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.
    Ma NF, Lau SH, Hu L, Xie D, Wu J, Yang J, Wang Y, Wu MC, Fung J, Bai X, Tzang CH, Fu L, Yang M, Su YA, Guan XY.
    Clin Cancer Res; 2008 Aug 15; 14(16):5061-8. PubMed ID: 18698024
    [Abstract] [Full Text] [Related]

  • 8. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI.
    Gastroenterology; 2007 Apr 15; 132(4):1476-94. PubMed ID: 17408664
    [Abstract] [Full Text] [Related]

  • 9. Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation.
    Zhang H, Shan CL, Li N, Zhang X, Zhang XZ, Xu FQ, Zhang S, Qiu LY, Ye LH, Zhang XD.
    Acta Pharmacol Sin; 2008 Apr 15; 29(4):473-80. PubMed ID: 18358094
    [Abstract] [Full Text] [Related]

  • 10. [Suppression of SMYD3 expression in HepG2 cell by shRNA interference].
    Xu JY, Chen LB, Xu JY, Yang Z, Wei HY, Xu RH.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Feb 15; 14(2):105-8. PubMed ID: 16494778
    [Abstract] [Full Text] [Related]

  • 11. [The effect of hepatitis B virus X protein on the c-met promoter activity in HepG2 cells].
    Xie B, Tang C, Chen P, Gou YB, Xiao J, DU H.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr 15; 17(4):292-6. PubMed ID: 19403030
    [Abstract] [Full Text] [Related]

  • 12. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
    Fu XY, Tan DM, Hou ZH, Hu ZL, Liu GZ, Ouyang Y, Liu F.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug 15; 20(8):598-604. PubMed ID: 23207154
    [Abstract] [Full Text] [Related]

  • 13. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
    Lin J, Zhu MH, Qu JH, Li FM, Ni CR.
    Ai Zheng; 2004 Jul 15; 23(7):749-55. PubMed ID: 15248906
    [Abstract] [Full Text] [Related]

  • 14. [The effect of hepatitis B virus X gene transfection on expression of human telomerase reverse transcriptase mRNA in human bile duct carcinoma cell lines].
    Qu ZL, Zou SQ, Wang X.
    Zhonghua Wai Ke Za Zhi; 2004 Oct 22; 42(20):1254-7. PubMed ID: 15598376
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack.
    Shan C, Zhang S, Cui W, You X, Kong G, Du Y, Qiu L, Ye L, Zhang X.
    Carcinogenesis; 2011 Aug 22; 32(8):1190-7. PubMed ID: 21665888
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus X protein mutant upregulates CENP-A expression in hepatoma cells.
    Liu L, Li Y, Zhang S, Yu D, Zhu M.
    Oncol Rep; 2012 Jan 22; 27(1):168-73. PubMed ID: 21956590
    [Abstract] [Full Text] [Related]

  • 19. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
    Peng Z, Zhang Y, Gu W, Wang Z, Li D, Zhang F, Qiu G, Xie K.
    Int J Oncol; 2005 Feb 22; 26(2):467-73. PubMed ID: 15645132
    [Abstract] [Full Text] [Related]

  • 20. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G, Chen X, Chen S, Ye W, Hou K, Liang M.
    J Transl Med; 2016 May 05; 14(1):122. PubMed ID: 27150195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.